These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6112771)

  • 21. The actions of antipsychotic drugs on dopamine receptors in the rat substantia nigra.
    Pinnock RD
    Br J Pharmacol; 1984 Apr; 81(4):631-5. PubMed ID: 6144343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Norepinephrine-dependent and independent mechanisms of persistent effects of amphetamine in rat cerebellum.
    Sorensen SM; Hattox S; Johnson SW; Bickford P; Murphy R; Freedman R
    Life Sci; 1985 Jun; 36(25):2383-9. PubMed ID: 3925266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of neuroleptic drugs on brain beta-endorphin immunoreactivity.
    Beal MF; Fisher J; Carr DB; Martin JB
    Neurosci Lett; 1985 Jan; 53(2):173-8. PubMed ID: 2858834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine autoreceptor and postsynaptic receptor blocking potency of neuroleptics.
    Kendler KS; Bracha HS; Davis KL
    Eur J Pharmacol; 1982 Apr; 79(3-4):217-23. PubMed ID: 6124428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological vs. clinical physiognomy of neuroleptics, with special reference to their sedative and antipsychotic effects.
    Nielsen IM
    Acta Psychiatr Belg; 1974 Sep; 74(5):473-84. PubMed ID: 4471027
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis.
    Zetterström T; Sharp T; Ungerstedt U
    Eur J Pharmacol; 1984 Oct; 106(1):27-37. PubMed ID: 6085051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of chronic risperidone on central noradrenergic transmission.
    Nasif FJ; Cuadra GR; Ramirez OA
    Eur J Pharmacol; 2000 Apr; 394(1):67-73. PubMed ID: 10771036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurochemical parameters in the hyperresponsive phase after a single dose of neuroleptics to mice.
    Hyttel J
    J Neurochem; 1979 Sep; 33(3):641-6. PubMed ID: 39118
    [No Abstract]   [Full Text] [Related]  

  • 29. Interactions of a neuroleptic drug (fluphenazine) with catecholamines in hippocampus.
    Palmer MR; Freedman R; Dunwiddie TV
    Psychopharmacology (Berl); 1982; 76(2):122-9. PubMed ID: 6805021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of alpha-adrenergic drugs on catalepsy induced by haloperidol or fluphenazine in rats.
    Wielosz M; Kleinrok Z; Włoch K; Zebrowska-Lupina I
    Pol J Pharmacol Pharm; 1978; 30(5):653-8. PubMed ID: 35783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Desipramine and noradrenergic neurotransmission in aging: failure to respond in aged laboratory animals.
    Bickford-Wimer PC; Parfitt K; Hoffer BJ; Freedman R
    Neuropharmacology; 1987 Jun; 26(6):597-605. PubMed ID: 3037423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the selective noradrenergic neurotoxin DSP4 on cerebellar Purkinje neuron electrophysiology.
    Bickford PC; Mosimann WF; Hoffer BJ; Freedman R
    Life Sci; 1984 Feb; 34(8):731-41. PubMed ID: 6422177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of acute and chronic amphetamine treatment on Purkinje neuron discharge in rat cerebellum.
    Freedman R; Marwaha J
    J Pharmacol Exp Ther; 1980 Mar; 212(3):390-6. PubMed ID: 7359342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiological effects of cyclazocine on rat cerebellar Purkinje neurons: comparison with phencyclidine.
    Kim M; Pang K; Freedman R; Palmer M
    Alcohol Drug Res; 1985-1986; 6(1):23-36. PubMed ID: 4074470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phencyclidine inhibition of cerebellar Purkinje neurons.
    Marwaha J; Palmer M; Hoffer B; Freedman R
    NIDA Res Monogr; 1981 Feb; 34():187-92. PubMed ID: 6783930
    [No Abstract]   [Full Text] [Related]  

  • 36. The paw test: a behavioural paradigm for differentiating between classical and atypical neuroleptic drugs.
    Ellenbroek BA; Peeters BW; Honig WM; Cools AR
    Psychopharmacology (Berl); 1987; 93(3):343-8. PubMed ID: 2893411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Piracetam interactions with neuroleptics in psychopharmacological tests.
    Bourin M; Poisson L; Larousse C
    Neuropsychobiology; 1986; 16(2-3):93-6. PubMed ID: 2884593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of clozapine, haloperidol and iloperidone on neurotransmission and synaptic plasticity in prefrontal cortex and their accumulation in brain tissue: an in vitro study.
    Gemperle AY; Enz A; Pozza MF; Lüthi A; Olpe HR
    Neuroscience; 2003; 117(3):681-95. PubMed ID: 12617972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrophysiological effects of phencyclidine and the sigma agonist ditolylguanidine in the cerebellum of the rat.
    Kim M; Bickford PC
    Neuropharmacology; 1992 Jan; 31(1):77-83. PubMed ID: 1311809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of neuroleptic drugs on serum and cerebrospinal fluid melatonin concentrations in psychiatric subjects.
    Smith JA; Barnes JL; Mee TJ
    J Pharm Pharmacol; 1979 Apr; 31(4):246-8. PubMed ID: 36465
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.